Published in Healthcare Mergers, Acquisitions and Ventures Week, March 15th, 2008
"This financing, together with the 'friends and family' private placement we recently completed, enables us to reach critical milestones for DAVANAT(R) and our fibrosis compounds," said Theodore Zucconi, Ph.D., President, Pro-Pharmaceuticals, Inc.
Keywords: Financing, Pharmaceutical Business, Pharmaceutical Company, Pro-Pharmaceuticals Inc., Pro-Pharmaceuticals Inc.
This article was prepared by Healthcare Mergers,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week